Skip to main content

Eversept Partners, LP

SEC CIK
0001697013
Latest filing
Aug 14, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ELV by Eversept Partners, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−30,195−100.0%Sold outHolders
Q4 202530,195$10.6M0.6%−14,785−32.9%ReducedHolders
Q3 202544,980$14.5M1.1%+26,018+137.2%AddedHolders
Q2 202518,962$7.38M0.7%+3,264+20.8%AddedHolders
Q1 202515,698$6.83M0.8%−13,480−46.2%ReducedHolders
Q4 202429,178$10.8M1.1%+9,713+49.9%AddedHolders
Q3 202419,465$10.1M0.8%+4,808+32.8%AddedHolders
Q2 202414,657$7.94M0.6%+264+1.8%AddedHolders
Q1 202414,393$7.46M0.6%−701−4.6%ReducedHolders
Q4 202315,094$7.12M0.7%−6,600−30.4%ReducedHolders
Q3 202321,694$9.45M1.0%+19,379+837.1%AddedHolders
Q2 20232,315$1.03M0.1%+2,315NewHolders
Q4 20220$00.0%−33,040−100.0%Sold outHolders
Q3 202233,040$15.0M1.8%−9,745−22.8%ReducedHolders
Q2 202242,785$20.6M2.0%+10,334+31.8%AddedHolders
Q1 202232,451$15.9M1.5%−1,843−5.4%ReducedHolders
Q4 202134,294$15.9M1.3%+2,666+8.4%AddedHolders
Q3 202131,628$11.8M0.9%+21,496+212.2%AddedHolders
Q2 202110,132$3.87M0.4%−53,760−84.1%ReducedHolders
Q1 202163,892$22.9M1.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.